Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/19890632

Download in:

View as

General Info

PMID
19890632